ASTATINE-211 LABELED MONOCLONAL-ANTIBODY - A POTENTIAL AGENT FOR RADIOIMMUNOTHERAPY
Publication
, Journal Article
GARG, PK; FRIEDMAN, H; SLADE, S; BIGNER, DD; ZALUTSKY, MR
Published in: EUROPEAN JOURNAL OF NUCLEAR MEDICINE
August 1, 1988
Duke Scholars
Published In
EUROPEAN JOURNAL OF NUCLEAR MEDICINE
ISSN
0340-6997
Publication Date
August 1, 1988
Volume
14
Issue
5-6
Start / End Page
245 / 245
Publisher
SPRINGER VERLAG
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
GARG, P. K., FRIEDMAN, H., SLADE, S., BIGNER, D. D., & ZALUTSKY, M. R. (1988). ASTATINE-211 LABELED MONOCLONAL-ANTIBODY - A POTENTIAL AGENT FOR RADIOIMMUNOTHERAPY. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 14(5–6), 245–245.
GARG, P. K., H. FRIEDMAN, S. SLADE, D. D. BIGNER, and M. R. ZALUTSKY. “ASTATINE-211 LABELED MONOCLONAL-ANTIBODY - A POTENTIAL AGENT FOR RADIOIMMUNOTHERAPY.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE 14, no. 5–6 (August 1, 1988): 245–245.
GARG PK, FRIEDMAN H, SLADE S, BIGNER DD, ZALUTSKY MR. ASTATINE-211 LABELED MONOCLONAL-ANTIBODY - A POTENTIAL AGENT FOR RADIOIMMUNOTHERAPY. EUROPEAN JOURNAL OF NUCLEAR MEDICINE. 1988 Aug 1;14(5–6):245–245.
GARG, P. K., et al. “ASTATINE-211 LABELED MONOCLONAL-ANTIBODY - A POTENTIAL AGENT FOR RADIOIMMUNOTHERAPY.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE, vol. 14, no. 5–6, SPRINGER VERLAG, Aug. 1988, pp. 245–245.
GARG PK, FRIEDMAN H, SLADE S, BIGNER DD, ZALUTSKY MR. ASTATINE-211 LABELED MONOCLONAL-ANTIBODY - A POTENTIAL AGENT FOR RADIOIMMUNOTHERAPY. EUROPEAN JOURNAL OF NUCLEAR MEDICINE. SPRINGER VERLAG; 1988 Aug 1;14(5–6):245–245.
Published In
EUROPEAN JOURNAL OF NUCLEAR MEDICINE
ISSN
0340-6997
Publication Date
August 1, 1988
Volume
14
Issue
5-6
Start / End Page
245 / 245
Publisher
SPRINGER VERLAG
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
- 0299 Other Physical Sciences